Laboratory Medicine ›› 2019, Vol. 34 ›› Issue (12): 1147-1149.DOI: 10.3969/j.issn.1673-8640.2019.12.019
Previous Articles Next Articles
Received:2018-11-09
Online:2019-12-30
Published:2020-01-03
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2019.12.019
| 项目 | 原倍 | 稀释倍数 | ||
|---|---|---|---|---|
| 2倍 | 4倍 | 8倍 | ||
| 实测值 | 16.30±6.44 | 15.72±5.14 | 13.68±5.02 | 11.21±4.38 |
| 理论值 | 16.30±6.44 | 8.15±3.22* | 4.08±1.61* | 2.04±0.81* |
| 项目 | 原倍 | 稀释倍数 | ||
|---|---|---|---|---|
| 2倍 | 4倍 | 8倍 | ||
| 实测值 | 16.30±6.44 | 15.72±5.14 | 13.68±5.02 | 11.21±4.38 |
| 理论值 | 16.30±6.44 | 8.15±3.22* | 4.08±1.61* | 2.04±0.81* |
| 组别 | 例数 | TSH （μIU/mL） | FT3 （ng/L） | FT4 （pg/mL） |
|---|---|---|---|---|
| 疑似干扰组 | 15 | |||
| ECLIA | 5.52±0.50* | |||
| CLIA | ||||
| 中和前 | 16.30±6.44 | 33.0±7.8 | 1.35±0.20 | |
| 中和后 | 4.02±0.30* | 32.6±8.0 | 1.38±0.18 | |
| 对照组 | 65 | |||
| ECLIA | 16.08±3.20 | |||
| CLIA | ||||
| 中和前 | 15.70±3.02 | 31.9±8.8 | 1.18±0.10 | |
| 中和后 | 16.00±2.52 | 32.2±6.0 | 1.14±0.15 |
| 组别 | 例数 | TSH （μIU/mL） | FT3 （ng/L） | FT4 （pg/mL） |
|---|---|---|---|---|
| 疑似干扰组 | 15 | |||
| ECLIA | 5.52±0.50* | |||
| CLIA | ||||
| 中和前 | 16.30±6.44 | 33.0±7.8 | 1.35±0.20 | |
| 中和后 | 4.02±0.30* | 32.6±8.0 | 1.38±0.18 | |
| 对照组 | 65 | |||
| ECLIA | 16.08±3.20 | |||
| CLIA | ||||
| 中和前 | 15.70±3.02 | 31.9±8.8 | 1.18±0.10 | |
| 中和后 | 16.00±2.52 | 32.2±6.0 | 1.14±0.15 |
| [1] | PEDROSA W,TEIXEIRA L.Interference of heterophilic antibodies with free prostate-specific antigen in the Beckman-Coulter(Unicel DxI) assay, inverting the free/total prostate-specific antigen ratio[J]. Ann Clin Biochem, 2009,46(Pt 4):344-345. |
| [2] | 黎锦,李一荣. 内源性抗体对临床免疫检测的干扰及对策[J]. 中华检验医学杂志,2016,39(11):811-813. |
| [3] | 黄婷,李卫星,张丽. 促甲状腺激素及甲状腺自身抗体与分化型甲状腺癌的关系研究[J]. 中国全科医学,2013,16(36):4258-4261. |
| [4] | 杨奕,章秋,邓大同. 药物对甲状腺功能及检测的影响[J]. 国际内分泌代谢杂志,2014,34(4):250-252. |
| [5] | HERMIDA J,TUTOR J C.Falsely increased blood tacrolimus concentrations using the ACMIA assay due to circulating endogenous antibodies in a liver transplant recipient:a tentative approach to obtaining reliable results[J]. Ther Drug Monit, 2009, 31(2):269-272. |
| [6] | 许诗珺,范建霞,杨帅,等. 不同促甲状腺激素和游离甲状腺素检测试剂对妊娠期甲状腺功能检测结果的影响[J]. 中华围产医学杂志,2015,18(2):81-86. |
| [7] | 徐艳秋,段伟,韦伟,等. 甲状腺功能检测在心血管内科的应用及意义[J]. 中西医结合心脑血管病杂志,2015,13(13):1573-1575. |
| [8] | 倪娟,高洪柳,王国洪,等. 化学发光法检测促甲状腺激素结果假性增高1例[J]. 临床检验杂志,2016,34(9):720. |
| [9] | FRITZ B E, HAUKE R J, STICKLE D F.New onset of heterophilic antibody interference in prostate-specific antigen measurement occurring during the period of post-prostatectomy prostate-specific antigen monitoring[J]. Ann Clin Biochem,2009,46(Pt 3):253-256. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
